Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVCN
2876
DELISTED
Neovasc Inc.
NVCN
| $509K | ﹤0.01% |
+17,449
| New | +$475K |
|
|
ACLX
2877
DELISTED
Arcellx
ACLX
| $508K | ﹤0.01% |
16,500
-34,300
| -68% | -$1.04M |
|
2878
Champions Oncology
CSBR
$69.5M
| $508K | ﹤0.01% |
126,491
-7,400
| -6% | -$31.6K |
|
2879
Ramaco Resources Class A
METC
$737M
| $508K | ﹤0.01% |
+59,638
| New | +$558K |
|
|
STRM
2880
DELISTED
Streamline Health Solutions
STRM
| $507K | ﹤0.01% |
18,785
+2,180
| +13% | +$61.9K |
|
|
AC
2881
DELISTED
Associated Capital Group
AC
| $503K | ﹤0.01% |
13,600
+100
| +0.7% | +$3.73K |
|
2882
Vanguard Consumer Staples ETF
VDC
$8.04B
| $503K | ﹤0.01% |
2,600
+900
| +53% | +$171K |
|
2883
Adobe
ADBE
$105B
| $502K | ﹤0.01% |
1,303
-50,834
| -98% | -$18.1M |
|
2884
Neonode
NEON
$15.7M
| $502K | ﹤0.01% |
+66,000
| New | +$544K |
|
2885
MaxCyte
MXCT
$140M
| $501K | ﹤0.01% |
+101,200
| New | +$498K |
|
2886
Vanguard Russell 1000 Value ETF
VONV
$22.1B
| $501K | ﹤0.01% |
7,500
-8,500
| -53% | -$576K |
|
2887
WisdomTree International SmallCap Dividend Fund
DLS
$1.08B
| $500K | ﹤0.01% |
8,200
-6,100
| -43% | -$374K |
|
2888
Scansource
SCSC
$1.07B
| $500K | ﹤0.01% |
+16,410
| New | +$510K |
|
2889
Value Line
VALU
$342M
| $498K | ﹤0.01% |
10,300
| – | – |
|
|
CASA
2890
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $498K | ﹤0.01% |
392,100
+8,700
| +2% | +$26.5K |
|
2891
IQVIA
IQV
$39.2B
| $497K | ﹤0.01% |
+2,500
| New | +$534K |
|
2892
Rigetti Computing
RGTI
$6.35B
| $497K | ﹤0.01% |
686,800
+162,106
| +31% | +$132K |
|
2893
CBIZ
CBZ
$2.96B
| $495K | ﹤0.01% |
10,000
+2,000
| +25% | +$96.3K |
|
2894
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
| $495K | ﹤0.01% |
+15,400
| New | +$486K |
|
2895
Solitario Resources
XPL
$74.8M
| $495K | ﹤0.01% |
748,171
-6,300
| -0.8% | -$4.28K |
|
2896
Biglari Holdings Class B
BH
$1.22B
| $494K | ﹤0.01% |
+2,919
| New | +$482K |
|
|
SRTA
2897
Strata Critical Medical Inc
SRTA
$526M
| $494K | ﹤0.01% |
146,100
+44,717
| +44% | +$182K |
|
2898
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
| $489K | ﹤0.01% |
16,427
-29,373
| -64% | -$876K |
|
|
ORTX
2899
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $489K | ﹤0.01% |
91,118
-93,110
| -51% | -$506K |
|
|
GURE
2900
Gulf Resources
GURE
$4.71M
| $488K | ﹤0.01% |
18,217
-840
| -4% | -$26.8K |
|
Similar funds
Jim Simons's Q1 2023 Portfolio in Review
As of Q1 2023, Jim Simons held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Jim Simons added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Jim Simons's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Jim Simons fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Jim Simons's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Jim Simons opened 524 new positions and closed 668 in Q1 2023.
- Jim Simons's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.